Unveiling therapeutic frontiers: DON/DRP-104 as innovative Plasma kallikrein inhibitors against carcinoma-associated hereditary angioedema shocks - a comprehensive molecular dynamics exploration
Crossref DOI link: https://doi.org/10.1007/s12013-024-01266-0
Published Online: 2024-06-13
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Oduro-Kwateng, Ernest
Soliman, Mahmoud E. S.
Text and Data Mining valid from 2024-06-13
Version of Record valid from 2024-06-13
Article History
Accepted: 29 March 2024
First Online: 13 June 2024
Compliance with ethical standards
:
: The authors declare no competing interests.